Procter & Gamble Health Ltd. · NSE:PGHL
Procter & Gamble Health — Investor Presentation (June 2026)
33 slides from Procter & Gamble Health's investor presentation, Jun 18, 2026
Slide 1: Letter to stock exchanges: Analysts/Institutional Investors Presentation
Date : June 18, 2026 To, To, The Corporate Relations Department The Listing Department The BSE Limited The National Stock Exchange of India Limited Department of Corporate Services Exchange Plaza, Plot No. C/1, G Block, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mu
Slide 2: Investor and Analyst Presentation
Investor and Analyst Presentation 18 June 2026
Slide 3: Disclaimer
Disclaimer This communication, except for the historical data, may contain forward-looking statements, including words, phrases, numbers that set forth anticipated results based on management’s current plans and assumptions. Forward-looking statements are based on current expectations and assumption
Slide 4: Investor and Analyst Presentation
Investor and Analyst Presentation 18 June 2026
Slide 5: Agenda
AGENDA • Business Results • Strategy and Fiscal Updates • Long term trends • Landscape
Slide 6: Fiscal Results 2025-26
Fiscal Results 2025-26
Slide 7: Delivered a Strong Year
DELIVERED A STRONG YEAR FY 2025-26 Strong, consistent Balanced Growth +16% +30% SALES PAT Considering that the company, effective last year, changed its Financial Year from July 1 –June 30 to April 1 – March 31, the last Financial Year of the Company covered a period of 9 months, from July 1, 2024,
Slide 8: Integrated Growth Strategy
INTEGRATED GROWTH STRATEGY PORTFOLIO PERFORMANCE DRIVES BRAND CHOICE SUPERIORITY ORGANIZATION TO WIN WITH CONSUMERS EMPOWERED • AGILE ACCOUNTABLE CONSTRUCTIVE DISRUPTION ACROSS OUR BUSINESS PRODUCTIVITY TO FUEL INVESTMENTS
Slide 9: Portfolio Performance Drives Brand Choice
PORTFOLIO PERFORMANCE DRIVES BRAND CHOICE
Slide 10: Portfolio
VITAMIN B IRON VITAMIN E (Nerve Health) PORTFOLIO VITAMIN B Trusted, Quality, Highly COMPLEX NASAL CARE OMEGA - 3 Recommended Brands
Slide 11: Superiority to Win with Consumers
SUPERIORITY TO WIN WITH CONSUMERS
Slide 12: Superiority to Win with Consumers
SUPERIORITY TO WIN WITH CONSUMERS PRODUCT PACKAGING COMMUNICATION RETAIL EXECUTION CONSUMER & CUSTOMER VALUE
Slide 13: Superior Innovations To Delight Consumers
Superior Innovations To Delight Consumers PRODUCT Easy-To-Consume Symptomatic Relief Superior Iron Supplement from Nerve Pain Fatty Liver Solution
Slide 14: Packaging that educates, and stands out in store
Packaging that educates, and stands out in store PACKAGING BEFORE AFTER
Slide 15: Livogen Iron Gummies
Livogen Iron Gumfpies help maffifain healthy iron levels. Read is for usage and other detailan This product is meant to didg@fose, freat, cure or prevent a
Slide 16: Neurobion
NEUROBION® NERVE PAIN METER i : ere street oe ee fet a ere, Stee fat eta, tee en Fata A ete wat oo ee enter @, aT, N eW Neu robion Cream Faraone tape & fare efea =el tafe sat ad & crenrrerMAR as ve, at gee ATA Alors S cea fe raTOT ee He Bt sew a Hew aA Te aT Ts Te, A pee A fee a ACT Al
Slide 17: Retail Execution
Amazon's Choice RETAIL EXECUTION Neurobion's Vitamin-B, RAKESH MEDICAL & GEN. STORES cuenisrs avo onvootsrs we Ateavasaa chi EEO Livogen Iron Gummies for Women, Kids & Adults | Maintains Haemoglobin, Iron... AAKKKKIKY 2K+ bought in past month
Slide 18: Productivity to Fuel Investments
PRODUCTIVITY TO FUEL INVESTMENTS
Slide 19: Productivity Integrated into the Strategy
PRODUCTIVITY INTEGRATED INTO THE STRATEGY Delivering the same or better output measures… with lower spending or resource investment. AD SPEND & MATERIALS MANUFACTURING OVERHEAD PROMOTION INR 35 crores productivity savings for FY 25/26
Slide 20: Constructive Disruption Across the Business
CONSTRUCTIVE DISRUPTION ACROSS THE BUSINESS
Slide 21: Constructive Disruption Across the Business
CONSTRUCTIVE DISRUPTION ACROSS THE BUSINESS Health Care Practitioners/ Health Care LEVERAGING EXTRA URBAN Organizations / EMERGING COVERAGE Chemist + CHANNELS EXPANSION (E-pharmacies, E-com, Q-Com) DISTRIBUTOR PARTNERSHIPS Winning model enabling Available to consumers Expanding reach to white- last
Slide 22: Organization
ORGANIZATION EMPOWERED • AGILE • ACCOUNTABLE
Slide 23: Prioritizing Employee Wellbeing
Prioritizing Employee Wellbeing Delivering Superior Employee Value Equation
Slide 24: Our Focus Areas
OUR FOCUS AREAS Healthcare Healthcare Accessibility Awareness Improving Creating Healthcare healthcare SUPPORTING ACCESS TO HEALTH accessibility awareness for CARE FACILITIES AND AWARENESS IN through mobile uptake of UNDERSERVED COMMUNITIES medical units Nutrition, Hygiene SINCE 2019 across 11 state
Slide 25: Driving Healthcare Access
DRIVING HEALTHCARE ACCESS Mobile Health Care Units Special Boat Clinic 25+K 1.8+L 1.1+L Free Treatments Kilometers VISITS FY26 Travelled
Slide 26: Driving Healthcare Awareness
DRIVING HEALTHCARE AWARENESS Yes To Poshan Initiative Healthcare For Children 55K 27 4000+ ~20K 30+ Lives Malnourished Children CCIs Supported Villages Children Impacted Impacted Each Year
Slide 27: Long Term Trends
LONG TERM TRENDS
Slide 28: Superior Results Over the Past 5 Years
SUPERIOR RESULTS OVER THE PAST 5 YEARS +7% +13% +42% CAGR CAGR Increase in NET SALES PAT ROE Note: 1) Basis Published results; 2) Net Sales refers to revenue from operations; 3) PAT Excluding OCI; 4) ROE = PAT/ Avg. Equity
Slide 29: Superior Results Over the Past 5 Years
SUPERIOR RESULTS OVER THE PAST 5 YEARS REVENUE FROM OPERATIONS (in INR Crs) PAT (in INR Crs) 327 1,408 1,008 177 2021 2022 2023 2024 2025* 2026 2021 2022 2023 2024 2025* 2026 Note: 1) *FY 24-25 was a 9-month year due to Fiscal Year change. For comparability, considered 12-month period from Apr 24 to
Slide 30: Creating Superior Shareholder Value
CREATING SUPERIOR SHAREHOLDER VALUE July 2016 Oct 2017 Jan 2019 Apr 2020 July 2021 Oct 2022 Jan 2024 Apr 2025 Mar 2026
Slide 31: Landscape
LANDSCAPE
Slide 32: Accelerating VMS category & emerging trends in India
Accelerating VMS category & emerging trends in India Steady growth of VMS Category Widespread Vitamin deficiency in 9% CAGR in last 3 years Indian population VMS Category - Value growth % Prevalence of deficiency 9% CAGR 10% Vitamin B12 47% 8% 8% Iron 37% 6% Vitamin D 70% Fatty Liver prevalence 38%
Slide 33: Q&A
Q&A
Procter & Gamble Health — Investor Presentation (June 2026) on 6ix